What is the latest status of the project “AbbVie $195M API Plant Expansion”?

The status recorded for “AbbVie $195M API Plant Expansion” is planned.

What is the budget and commercial profile for the project “AbbVie $195M API Plant Expansion”?

Taiyo normalizes the budget of “AbbVie $195M API Plant Expansion” to USD 195000000.

Where can I verify the source and access all details for “AbbVie $195M API Plant Expansion”?

This Taiyo project page references Fierce Pharma along with the original URL (https://www.fiercepharma.com/manufacturing/abbvie-plans-195m-api-plant-illinois-part-us-investment-campaign). Taiyo standardizes official data into a consistent, searchable project profile.

AbbVie $195M API Plant Expansion

Sector: Manufacturing (Industrial) • Location: North Chicago, Illinois, United States

Source: Fierce Pharma

Project

Planned

AbbVie plans to spend $195 million to expand its manufacturing presence in North Chicago, Illinois, by constructing a facility to produce active pharmaceutical ingredients. The construction is set to begin in the fall and the plant is expected to be fully operational in 2027. This project is part of AbbVie's $10 billion investment plan in the U.S. to support production of current and next-generati

Status: Prospective
Sector: Manufacturing (Industrial)
Location: North Chicago, Illinois, United States of America
Updated: 22 Jul 2026
Source: Fierce Pharma

ConstructChat

Ask ConstructChat about AbbVie $195M API Plant Expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “AbbVie $195M API Plant Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in North Chicago, Illinois, United States. Taiyo aggregates data on it from Fierce Pharma.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	AbbVie plans to spend $195 million to expand its manufacturing presence in North Chicago, Illinois, by constructing a facility to produce active pharmaceutical ingredients. The construction is set to begin in the fall and the plant is expected to be fully operational in 2027. This project is part of AbbVie's $10 billion investment plan in the U.S. to support production of current and next-generation therapies in neuroscience, immunology, and oncology.
Original sector	Pharmaceutical Manufacturing
Budget

Location

Country	United States of America (USA)
State	Illinois
City	North Chicago

Source

Source	Fierce Pharma
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-08-14

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

AbbVie $195M API Plant Expansion

Ask ConstructChat about AbbVie $195M API Plant Expansion

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States